Kumiai Chemical Industry Co., Ltd. (TSE:4996) entered into an agreement to acquire Bensulfuron-Methyl business in Asia Pacific Countries, excluding China from Corteva, Inc. (NYSE:CTVA) on September 6, 2019. The agreement is expected to close in late September/early October.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
53.56 USD | -0.14% | +2.12% | +11.60% |
06-25 | RBC Capital Adjusts Price Target on Corteva to $62 From $64 | MT |
06-18 | Mizuho Securities Adjusts Price Target on Corteva to $60 From $61 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.60% | 37.39B | |
-.--% | 11.72B | |
+19.14% | 7.8B | |
-9.79% | 7.09B | |
+8.88% | 6.85B | |
-10.29% | 5.62B | |
-12.46% | 5.24B | |
-3.31% | 5.13B | |
+28.14% | 5.05B | |
+5.71% | 3.95B |
- Stock Market
- Equities
- CTVA Stock
- News Corteva, Inc.
- Kumiai Chemical Industry Co., Ltd. entered into an agreement to acquire Bensulfuron-Methyl business in Asia Pacific Countries, excluding China from Corteva, Inc..